Catalyst Wire Dossier Catalyst Wire Dossier

MACRILEN

macimorelin acetate · Aeterna Zentaris GmbH
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for MACRILEN, covering 2017-12-20 to 2026-07-23. Get the full timeline:

Most recent: FDA Approved: MACRILEN — Supplemental Application (Aeterna Zentaris GmbH)

See pricing